Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Liabilities and Shareholders Equity: 2011-2025

Historic Liabilities and Shareholders Equity for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $430.4 million.

  • Mesa Laboratories' Liabilities and Shareholders Equity fell 5.23% to $430.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 16.81%. This contributed to the annual value of $433.3 million for FY2025, which is 3.01% down from last year.
  • Per Mesa Laboratories' latest filing, its Liabilities and Shareholders Equity stood at $430.4 million for Q3 2025, which was down 1.24% from $435.7 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Liabilities and Shareholders Equity registered a high of $741.8 million during Q4 2023, and its lowest value of $430.4 million during Q3 2025.
  • For the 3-year period, Mesa Laboratories' Liabilities and Shareholders Equity averaged around $523.4 million, with its median value being $446.8 million (2024).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 47.02% in 2021, then crashed by 41.58% in 2024.
  • Over the past 5 years, Mesa Laboratories' Liabilities and Shareholders Equity (Quarterly) stood at $721.7 million in 2021, then fell by 8.14% to $663.0 million in 2022, then grew by 11.88% to $741.8 million in 2023, then plummeted by 41.58% to $433.3 million in 2024, then dropped by 5.23% to $430.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $430.4 million in Q3 2025, compared to $435.7 million in Q2 2025 and $433.3 million in Q1 2025.